GlassScriptPhysician profile
Anthony S Rhorer
NPI 1548265606
$65,795.67
in general payments reported to CMS, 2019-2025
11 companies · $19K in 2025
The $19K reported for 2025 was more than what 84% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $3,417 · 2021: $779 · 2022: $18K · 2023: $16K · 2024: $8,194 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $43K · Food and Beverage: $83.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $43,184.41 |
| Food and Beverage | $83.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $60,925.70 | 2019-2025 | Troch Nail, Autobahn |
| Stryker Corporation | $2,564.77 | 2020-2022 | |
| Smith+Nephew, INC. | $1,316.97 | 2019-2023 | Large Cannulated Screws, Tandem, Tc-100 |
| US Implant Solutions, LLC | $641.88 | 2021-2022 | |
| Cerapedics INC. | $129.96 | 2021 | |
| Depuy Synthes Sales INC. | $95.62 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $30.94 | 2022 | |
| Bioventus LLC | $30.09 | 2023 | Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Bone Support INC. | $23.05 | 2021 | |
| Abbott Laboratories | $22.73 | 2024 | Eterna |
| Sanara Medtech INC. | $13.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Rhorer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.